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Abstract: Nutritional and ergogenic aid supplementation is prevalent within athletic or general
fitness populations, and is only continuing to gain momentum. Taken in isolation or as a combination,
amino acid (AA) supplementation has the potential to increase endurance performance among other
benefits. L-Arginine (L-Arg) and L-Citrulline (L-Cit) are two AAs proposed to increase endothelial
nitric oxide (NO) synthesis, with potential additional physiological benefits, and therefore may
contribute to enhanced performance outcomes such as increased power output, or time to exhaustion.
However, the appropriate dose for promoting physiological and performance benefits of these AAs,
and their potential synergistic effects remains to be determined. Therefore, the aim of this review
was to evaluate the varied concentrations used in the current literature, assess the effects of L-Arg
and L-Cit in combination on physiological responses and endurance performance, and consider if
there is a fundamental basis for providing these supplements in the form of a beverage. A total
of six studies were considered eligible for the review which utilized a range of 3–8 g of the AA
constituents. The findings support the notion that supplementing with a combination of L-Arg and
L-Cit may increase NO production, enhance vasodilation, and therefore increase performance capacity
in athletes. A beverage as a carrier for the two AAs is worth considering; however, there remains
limited research assessing these outcomes across a consistent range of concentrations in order to see
their full potential.
Keywords: L-Arginine; L-Citrulline; performance; exercise; vasodilation; functional beverage
1. Introduction
Supplementation and athletic performance share a long history [1,2]. There is a continual search
for the latest supplements for enhancing athletic performance, reducing fatigue and recovery time,
and providing a ‘competitive edge’ [1]. However, due to the relatively easy addition of supplements to
a diet or training regime, they are often misused or used in the absence of evidence supporting their
claims [3,4]. Amino acids (AAs) are the basic building blocks of proteins, which play an essential role
in the body for cellular signaling and transport [5]. These signaling and transport proteins affect basic
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physiological functioning through mediating the bioavailability of nutrients and gene expression and
are, therefore imperative constituents to overall health [5,6]. The categorization of AAs as a whole fall
into two pools: non-essential, which can be synthesized solely within the body, and essential, which
cannot, and therefore are required to be consumed and obtained from the diet [5,6]. The consumption
of different AAs as supplements are proposed to enhance athletic performance, predominately by
increasing blood flow to skeletal muscle, and in turn, improving performance capacity [4,7]. Two AAs
in particular, Arginine (L-Arg) and Citrulline (L-Cit), are commonly used as sporting supplements
and have been studied for their inhibition of exercise-induced fatigue and vasodilatory effects which
can subsequently result in enhanced performance including increased power output, reduced energy
expenditure, and improved time to exhaustion [8–10]. Over the last few decades, numerous members of
the AA family have been studied, some at great length, for their potential to modify these physiological
attributes [4]. L-Arg and L-Cit are relatively recent AAs of interest due to their potential synergistic
and potent vasodilatory effects [11,12], and in addition are also easily accessible and readily available
to consumers in today’s supplement market [4,13]. While studies have assessed the benefit of these
AAs in human and animal trials, there is some degree of variance in concentrations administered,
commonly between 3 and 6 g of L-Arg and 3 and 8 g of L-Cit. As such, it remains difficult to assess the
presence or magnitude of any performance benefits that are elicited, due to such varied dose ranges.
As an essential AA in adults, the main dietary sources of L-Arg are lean meats, nuts, seeds,
and legumes [14]. While playing a major role in protein synthesis, L-Arg has also demonstrated
improvements to endothelial and immune function, reduced oxidative stress and vasodilation through
increasing the generation of nitric oxide (NO) [14,15]. The development and production of NO is
considered one of the most important factors associated with vasodilation of the cardiovascular
system [16]. Furthermore, vasodilation is an integral component of the maintenance of vascular health,
where the endothelium (cells that line the interior surface of blood and lymphatic vessels) produces
several vascular responses that are important in the regulation of vascular tone [16,17]. The increase
and maintenance of NO levels proposed from L-Arg supplementation can have additional, potentially
beneficial effects during exercise and the compensatory vasodilation may result in improved exercise
capacity, as well as possibly reducing oxygen (O2) cost of moderate intensity exercise [11,14].
Traditionally, a non-essential AA, L-Cit can be found in some fruits such as watermelon, melons,
and pomegranates [18]. Synthesized from several overlapping pathways, L-Cit acts as a pivotal
point in the central reaction of the urea cycle, mediating the removal of ammonia in the body [18,19].
L-Cit also acts as a precursor to L-Arg, as it becomes actively converted into L-Arg via enzymatic
hydrolysis [17,19,20]. Increased plasma levels of L-Cit have been associated with a protective role in
oxidative damage and supporting the maintenance of ‘normal’ functioning of the cardiovascular system
due to its role in NO metabolism [21,22]. Relatively recent studies have indicated that supplementing
with a combination of L-Arg and L-Cit could potentially increase plasma L-Arg concentration and
rapidly enhance NO bioavailability [13,21]. However, the use of these two AA reports a mixed
consensus on their effects as nutritional ergogenic aids, both individually and in combination, likely
due to a lack of consistency in concentrations tested (mainly <6 g each) as acute supplements [9,23].
Among other things, endurance performance depends on the interaction between a number of
central and peripheral physiological factors [24]. A major factor differentiating endurance performance
is running economy (RE), defined as the energy demand for a given velocity of submaximal running,
and can be determined by measuring steady-state consumption of oxygen [25]. Cardiovascular
responses, oxygen delivery to, and utilization by the tissues during exercise, play a fundamental role
in determining RE and overall performance [24]. In addition, NO bioavailability has the potential to
modify endurance performance with a specific focus on cardiovascular responses (via vasodilation),
and supplementation with L-Arg and/or L-Cit may be an underlining driver to potentially optimize
these processes.
Despite the associated physiological benefits of L-Cit and L-Arg in concentrations ranging
from 3 to 8 g, few studies have investigated the effectiveness of these AAs in athletic, recreational,
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and non-recreational individuals [13,26,27]. Generally, studies using either AAs or both in combination,
have investigated predominantly physical and perceived parameters of exercise such as blood pressure
(BP), sprinting time, jump height or Rating of Perceived Exhaustion (RPE) [9,12,28]. However, to date,
an assessment of these outcomes against the diverse range of concentrations administered has not
been performed. Therefore, the purpose of this review is to evaluate the range of L-Arg and L-Cit
concentrations used in eligible studies, assess the effects of both AAs (individually or in combination)
relating to performance outcomes, and to consider if there is a fundamental basis for providing these
supplements in the form of a beverage.
2. Methods
Literature searches were performed in a non-systematic manner to assess the effectiveness of
two commonly used AA, L-Arg and L-Cit as a combined supplement, on performance outcomes.
Four electronic databases were searched (PubMed, Cochrane Library, Web of Science, and SCOPUS)
using the terms “L-Arginine” OR “L-Citrulline” AND “athletes” AND “performance”, (human and
animal trials) in addition to manual searches of the identified article reference lists. Only peer-reviewed,
randomized control trials published in the English language were of interest to the review. In particular,
studies that used greater than 3 g of each supplement constituent in humans (or 0.05 g/kg of body
mass) and at least 1.43 mmol·kg−1 of animal body mass were considered, based on inclusion criteria
from previously published systematic reviews and meta-analyses [12,29]. Studies with a sample
population considered ‘healthy’, placebo group as a comparator, and performance variables resulting
from an exercise intervention in a trained population were of interest. All evidence was synthesized
under the themes of AA bioavailability, vasodilation and NO biomarkers, physiological response,
and performance outcomes as well as potential synergistic effects of both AAs. Results of the studies
have been synthesized in Table 1.
3. Background
3.1. Prevalence of Supplementation in Athletic and Recreational Populations
Supplementation for competitive or recreational use is widespread in today’s society, and it
has become increasingly popular in recent years [1]. Results of a survey in 2016, indicated around
50% of athletes are taking supplements regularly, although this does not capture the ‘irregular’
supplement users, or what a particular individual might define as a ‘supplement’ [30,31]. While
the prevalence of supplementation has not necessarily increased over the period of a few years,
a study by Shaw et al. (2016) observed a greater amount of supplements being used within the same
populations [30]. In general, a number of different supplementation products are becoming increasingly
available and predominately sold as food supplements such as gels, bars, protein powders, or beverages.
These products also contain a plethora of caffeine, different sugars and other ingredients (e.g., herbal
extracts) that might be more attributable to an increased performance outcome than the ‘active’ ingredient
itself [2]. In addition, these beverages are also sources of an arbitrary combination of vitamins, minerals,
and herbs; mixed with ergogenic aids such as nitrates (beetroot juice), and creatine, with the majority
having limited or no scientific support behind their consumption [32]. Several institutions, such as the
Australian Institute of Sport (AIS), provide a framework of supplement classifications, which includes
an educational tool to rank sports foods and supplements (and their ‘functional’ ingredients) according
to their scientific evidence and safety, allowing a practical contribution to an individual’s performance
goals [32]. In 2018, the International Olympic Committee (IOC) released a consensus statement on
supplements and the high-performance athlete, indicating supplement use varied between different
sports or activities [31]. This also increased with age, the level of training or performance, and was
strongly influenced by perceived cultural and social norms [31]. Overall, an individual’s motivation
for supplement use is mainly attributable to the proposed health benefits, such as preventing nutrient
deficiencies that may hinder performance or impair health, while supplementing for the purpose of a
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direct performance outcome was only secondary [30,31]. This further iterates the importance of using
supplements that are evidence-based, and designed with the individual in mind. With supplements
being increasingly consumed by active individuals, could the burden of handfuls of capsules, tablets
or powders be alleviated through convenient and specifically developed beverages?
3.2. L-Arginine
One of the popular nutritional supplements is L-Arg, which is reported to have potentially
beneficial effects on athletic performance and health in general [16]. It has been previously established
that L-Arg’s key roles in the health and upkeep of cardiac and skeletal muscles are important in the
regulation of homeostasis and hemodynamics of the body [16,33], including its mediation of creatine
synthesis and growth hormone release [34]. These parameters, in addition to the requirement of
L-Arg for NO production, outline the integral role of L-Arg in vascular function, and skeletal muscle
maintenance [34]. In endothelial cells, NO is synthesized from L-Arg by eNOS and induces smooth
muscle relaxation through guanylate cyclase activation [35,36]. For this reason, it has been proposed
circulating L-Arg in the blood produced by oral administration, may represent a possible therapeutic
mechanism to increase the synthesis and bioavailability of NO [13].
3.3. L-Citrulline
The consumption of L-Cit, known for its vasodilatory and NO production properties, has been
postulated to increase muscular repair and accelerate wound healing. In addition, many of the
health-related applications of L-Cit supplementation are primarily centered on the capacity for L-Cit to
increase the availability of L-Arg for NO production [22]. Unlike L-Arg, L-Cit is transported directly
to the kidneys after ingestion, where it is then catabolized into L-Arg by arginosuccinate enzymes
(synthase and lyase) [37]. Due to the suggested vasodilation activity, supplementation with L-Cit
is thought to affect exercise performance positively, gaining increased interest in the sporting and
nutrition fields [28]. However, currently, ambiguity surrounding the effects of acute vs. chronic L-Cit
supplementation, the method of delivery, and particular considerations in terms of the bioavailability
of the supplement, all remain to be confirmed [28].
3.4. The Bioavailability of L-Arg and L-Cit
A number of different factors are associated with affecting the bioavailability of AA, including their
chirality (L- or D- forms), concentrations provided, site of absorption, gastrointestinal health, transit
time through the gastrointestinal tract and food matrix in which they are consumed [38,39]. Therefore,
the mode of delivery has a strong potential to influence AA absorption, potentially making them more
readily available in the body, as it may interact with several different factors resulting in a difference in
the speed of the absorption or in some cases, even impaired absorption [39]. As most of the essential AA
are usually consumed as dietary sources in the form of protein-containing foods, after ingestion they
are absorbed relatively slowly and undergo extensive systemic and pre-systemic elimination [21,39,40].
In contrast, non-essential AA can be readily absorbed (specifically the L-forms) relatively quickly,
and can also further contribute to the synthesis of essential AA in most cases [21]. Orally available AA
supplements are often consumed as a pressed tablet, capsule, or powder, and often other ingredients
are added to lessen an unfavorable taste if provided in liquid form [41]. However, the physiologically
relevant responses may exceed consumption of the several grams range, and consequently, providing
capsules might not necessarily be the most effective and convenient way of supplementation [42].
The combination of AA in beverage supplements, other liquid forms and in some pre-prepared food
products can also affect the bioavailability of the AA. Hence, subsequent effects cannot be solely
attributed to the particular compound being marketed [42,43]. Interestingly, a pharmacokinetic
study [21] assessing doses of both L-Arg and L-Cit ranging from 5 to 10 g, demonstrated L-Cit is more
readily absorbed and bioavailable compared with L-Arg. Although from a performance perspective,
Ermolao et al. (2017), observed no significant in sprint time when supplementing with 3 g of L-Arg in a
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500 mL carbohydrate (CHO) beverage (Total CHO 26.7 g) [44]. However, the effect that this may have
had on the binding of the AA with the CHO matrix was not considered [44]. Unfortunately, there is a
lack of recent pharmacokinetic studies on L-Cit and L-Arg despite the need to determine an effective
dose range or upper limit, nor how ingesting food before or alongside supplementation may interact
with its metabolism in the body. This reiterates the need to explore the effects of these AA and their
combination in potentially higher doses (6 g and greater) as they are reported to be relatively safe and
are currently largely unexamined [40,44]. Moreover, there is growing interest to support the potential
health properties of these AA surrounding their performance enhancing, and general beneficial health
properties, including vasoactivity [40,44].
4. Discussion of Results
4.1. L-Arg and L-Cit on Vasodilation and NO Biomarkers
The endothelial-derived vasoactive factor, NO, is a potent signaling molecule that plays a
major role in vasodilatory capacity and thereby increasing oxygen uptake in skeletal muscle [45].
L-Arg is a substrate for vascular NO (Figure 1), and endothelial NO synthase (eNOS)–dependent NO
formation [14]. It has also been proposed that endogenous NO production is dependent on extracellular
L-Arg concentration, and therefore, by increasing extracellular L-Arg levels, NO-dependent vasodilation
will also be enhanced [27,46]. A study by Bailey et al. (2016), reported a significant increase (p < 0.05)
in NO production when supplementing with standalone L-Arg (6 g) and tended to increase with
standalone L-Cit (p = 0.08) at concentrations of 6 g when compared with placebo [46]. In an animal
study by Morita et al. (2014), rats and New Zealand white rabbits received either 2.85 mmol/kg of
L-Cit, 2.85 mmol·kg−1 of L-Arg or 1.43 mmol·kg−1 of each in combination, to assess the acute effects
on NO and blood flow [13]. This L-Arg/L-Cit combination caused NO bioavailability and blood flow
(measured in the central ear artery) to increase more rapidly when compared with the other treatment
groups (p < 0.05) [13]. While promising, a caveat for future studies was that the dosage used was
relevant to the weight of the animal; however, it is stated in the article that relatively large dosages
(5–15 g daily) would be required to improve endothelial function in humans [13].
4.2. L-Arg and L-Cit on Physiological Response and Exercise Performance Outcomes
Relatively recent studies have investigated the effects of both L-Arg and L-Cit supplementation
on physiological responses and improving exercise performance [9,10,26,27,35,44,46–48]. Exercise
intensity (i.e., velocity or power output) refers to the amount of work that can be accomplished to
perform a given activity, often expressed as a percentage of an individual’s VO2max, or maximal power
output, both typically measured using incremental exercise testing [49]. Exercise capacity refers to the
ability of an individual to perform at a specific workload intensity [50].
Together with physiological responses associated with the autonomic nervous system (ANS) such
as heart rate, heart rate variability and blood pressure, sub-maximal and maximal oxygen consumption
(VO2) and exercise economy, to name a few, are factors directly affecting the performance of an
individual [51]. A study by Bailey et al. (2015), compared L-Arg and L-Cit individual supplementation
on running economy and exercise performance in active males [46]. After acute supplementation
with 6 g of L-Arg and 6 g of L-Cit, the authors reported no significant effects (p > 0.05) on either
running economy or overall exercise performance after a moderate intensity cycle compared with
placebo. This study, however, did not assess the potential effects of the AA in combination. In contrast,
Chen et al. [10] assessed running economy in 12 athletes using L-Arg and L-Cit in combination using
an oral tablet. The treatment group, who received 0.05 g/kg of body weight of L-Arg/L-Cit, improved
performance over two consecutive days compared with PL (p = 0.002) [10]. Similarly, Hsueh et al.
(2018) reported male swimmers improved high-intensity interval training performance after a 50-m
swim when supplementing with an average of 3.2 g for both L-Arg and L-Cit (average based on
AA 0.05 g/kg body weight). [27]. While the studies assessing both L-Arg and L-Cit in combination
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had relatively small sample sizes (n = 10–24), overall, enhancing cardiorespiratory efficiency through
NO modulation with a combination of L-Arg and L-Cit was seen to more efficiently enhance VO2
kinetics (pulmonary O2 uptake)—a valuable outcome in endurance athletes by positively affecting
power output and metabolic responses. It is for these reasons that L-Arg and L-Cit require further
investigation, specifically given their potential to enhance physiological responses, either as standalone
supplements or in combination.
Figure 1. L-Arg, L-Cit and their role in vasodilation. Step 1. Citrulline in systemic circulation is
metabolized in the kidneys by ARGs to form L-arginine. Step 2. L-arginine is released systemically
into blood vessels. Step 3. L-arginine is transported into endothelial cells via CAT transporters and
eNOS to produce nitric oxide (NO). Step 4. NO diffuses from endothelial cells into skeletal cells.
Step 5. NO presence and activation of GC and GTP produces cGMP causing cellular calcium efflux,
leading to vasodilation. Abbreviations; ARGs = arginosuccinate synthase; CAT = cationic amino
acid transporter; eNOS = extracellular nitric oxide synthase; NO = nitric oxide; GTP = guanosine
triphosphate; GC = guanylyl cyclase; cGMP = cyclic guanosine monophosphate. Figure 1 was provided
as a courtesy by Mr. Jackson Williams.
4.3. Potential Synergistic Effects of L-Arg and L-Cit
The effects of L-Arg are known to be hampered by its absorption due to intestinal arginase
activity [39]. While L-Cit is made available rather quickly, it can also be metabolically converted
into L-Arg, thus showing potential for a synergistic relationship between the two [14,52]. While only
four known studies [10,13,26,27], to our knowledge, have assessed both AA in combination, it cannot
be ruled out that their combined consumption has the potential to be more efficient in achieving
improved performance outcomes. Three human trials [10,26,27] identified in this review, while having
relatively small sample sizes (12–16 participants), still found enhanced responses for their collective
outcome measures of fatigue modification and exercise performance. Previous human pharmacokinetic
studies [21,40] have demonstrated the ‘recycling’ mechanism of L-Arg through the involvement of
L-Cit in the urea cycle, and have focused on the suggestion that increasing L-Cit would result in
increased plasma L-Arg [40]. From the studies assessed in this review, it can be speculated that due to
their synergistic effects, supplementing with a combination of L-Arg and L-Cit may be more effective
than supplementing with the individual AA, due to the potential for increased bioavailability and the
reuptake of L-Arg [13,40]. However, there is no consensus on the appropriate concentration of each
AA when used in combination, and if it is possible to achieve the expected results with a lesser dose
but with chronic supplementation, compared with acute supplementation with a higher dose.
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Table 1. Summary of studies which tested L-Arginine and L-Citrulline in combination in humans and animal studies.
Author, Year Participants(n) Objective Outcomes Concentration of Supplement Strengths Limitations
Bailey et al.,
2015 [53] n = 10
To compare the effects of L-Cit
and L-Arg supplementation on
NO biomarkers, V˙O2 kinetics,
and exercise performance.
Plasma NO concentration was
increased with L-Arg
supplementation (p < 0.05) and
tended to increase with L-Cit
supplementation (p = 0.08)
compared with PL. V˙O2 during
moderate-intensity cycle exercise
was not significantly different
(p > 0.05).
6 g (of each)
Due to the short study design, a
familiarization and baseline
testing session was conducted to
discount a ‘learning effect’ in
exercise testing.
Short study duration
(seven days) and small
sample size (n = 10).
Chen et al., 2016 [10] n = 12
To investigate the effect of the
combination L-Arg and L-Cit on
central fatigue.
Significantly better response time
measured in AA group
compared with PL.
0.05 g/kg of body weight (of each)
Previously tested the point after
supplementation when plasma
L-Arg would peak, and began
testing protocol 1-h
after supplementation.
Small sample size
(n = 12).
Cheng et al.,
2016 [26] n = 13
To investigate the combination
of L-Arg and L-Cit on
endurance performance.
AA group significantly better in
two endurance running
distances on both days.
0.05 g/kg of body weight (of each) Testing protocol was repeated aday later to validate outcomes.
Assessed acute effect of
supplementation with
one day washout
period—potential
accumulation of plasma
AA not discussed?
Hsueh et al.,
2018 [27] n = 16
To examine the effect of
co-ingestion of L-Arg and L-Cit
on high-intensity interval swim
performance in trained
young swimmers.
Average swim time was shorter
in treatment group when
compared with PL. RPE was
similar between the two groups.
0.05 g/kg of body weight (of each)
Testing protocol began one hour
after supplementation to allow
for peak plasma levels.
Relatively small sample
size (n = 16).
Morita et al.,
2014 [13]
[animal]
n = 24
To investigate the acute effects of
a combination of oral L-Cit and
L-Arg on plasma L-Arg and NO
levels, as well as on
blood circulation.
L-Arg and L-Cit combined
caused a more rapid increase and
enhancement of NO
bioavailability compared with
single individual AA.
2.85 mmol·kg−1 (of each) animal body
weight, and 1.43 mmol/kg of
combined L-Arg/L-Cit
Strong study design, highlights
future direction for
human studies.
Animal trial—not
directly transferrable?
Silva et al., 2017 [8] [animal]n = 40
To evaluate the effects of
supplementing with L-Arg and
L-Cit on performance and
oxidative stress in trained and
untrained rats
Supplementation improved
physical performance in both
control and trained groups.
300 mg/kg animal body weight
Strong study design,
highlights future direction for
human studies.
Animal trial—not
directly transferrable?
Key: L-Arg = Arginine; L-Cit = Citrulline; PL = placebo; RPE = Rating of Perceived Exhaustion; NO = Nitric Oxide; AA = Amino Acids; BMI = Body Mass Index; CM = Citrulline Malate;
RSA = Repeated Sprint Ability.
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While there is relatively strong evidence related to improved sports performance, vasodilation
and NO production after supplementation with L-Arg and L-Cit individually, trials assessing a
combination of L-Arg and L-Cit are still relatively scarce. There is conflicting evidence relating to the
most appropriate and effective concentration of both AA, and larger trials are needed in order to assess
the true potential of L-Arg and L-Cit as a combined nutritional ergogenic aid.
5. Summary of Key Findings and Future Directions
Despite the consistent yet still emerging use of sporting supplements, there remains a lack
of consensus underlying their effectiveness. Supplementation with L-Arg and L-Cit still requires
further investigation using larger sample sizes, a consistent range of AA concentrations and timing of
administration, to determine the optimal effect on physiological parameters. There also lies a general
acceptance that the ratio at which L-Arg and L-Cit should be consumed in combination, typically a 2:1
L-Cit to L-Arg, as opposed to a 1:1 ratio, which may alter the effectiveness of functional beverages
which contain both AAs. However, further research is needed to determine the optimal quantities
of each AA required to be consumed in order to potentially exhibit beneficial effects in performance.
Additionally, by providing supplementation in the form of a functional beverage, there is potential for
more natural consumption of the product during various types of athletic events (i.e., running, weight
lifting, and swimming), and whether the timing of supplementation could be spaced out and delivered
at the most critical time points to promote improved performance.
Taking into account that sports beverages are primarily developed and formulated to be effective
in improving performance, and to provide hydration and a cooling effect when required, traditionally,
there are no universal agreements for the most efficacious formulations. The main reason for this
could be seen in the versatility and convenience in the use of sports drinks. For example, regardless
of formulation, a particular beverage could be used in several different sports or physical activities
and more recently, their availability on the market has provided opportunities for use in general
populations too. This requires a level of likeness or acceptability of a particular product in order to
be selected by everyday individuals or recreational athletes—which in the case of L-Arg and L-Cit,
in addition to the competitive nature of product development, can be a difficult obstacle. Although
the flavor modulation in beverages is achieved with the use of sweeteners (carbohydrates, artificial
and semi-artificial sweeteners), salts and encapsulation, it is important to select ingredients that will
not interfere with the stability or in some cases the absorbability of the active compounds. Some of
the potential avenues could include pH-sensitive encapsulation of the active ingredients targeting
specific sites of absorption in the small intestine while masking the potential undesirable flavor of the
active ingredients. Additionally, many of the commercially available L-Cit supplements currently on
the market today are commonly prepared with citrulline malate, and future studies should look to
investigate any differences in effectiveness between the salt and isolated compounds.
6. Conclusions
A beverage that provides the potential ergogenic benefits of L-Arg and L-Cit supplementation in
the convenience of a sports drink with the tested stability of the active ingredients and flavor adaptation
to make it more palatable is worth considering. Overall, there remains a relatively mixed consensus
surrounding the quantities of L-Arg and L-Cit that need to be consumed to elicit the most beneficial
effects in humans, while animal studies have highlighted a path for future human studies and potential
mechanisms of action. Further research should assess these outcomes across a range of concentrations
in order to see the full potential in the delivery of these AA on endurance performance for immediate
use pre-, during- and post-event within the athletic, recreational sport, and general populations.
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